Hepatitis B virus (HBV) has a narrow host range, mainly infecting hominoids. A new study reveals the structural differences in the liver cell receptor (NTCP) between humans and monkeys, explaining why ...

An infection with the hepatitis B virus (HBV), which is spread by blood or bodily fluids, is one of the main causes of ...

New research has illustrated how hepatitis A virus uses cellular proteins, like PDAP1, to infect liver cells, replicate and ...

A study reveals why monkeys resist HBV infection, showing that specific amino acid differences in their NTCP receptor prevent ...

Hepatitis B virus (HBV) infection is a leading cause of chronic liver diseases, that spreads among individuals through blood or body fluids.

Even though an excellent vaccine has been available since the 1990s, there have been 45,000 confirmed cases of hepatitis A, ...

Tune Therapeutics, an epigenome-editing company based in Durham and Seattle, will be the first to initiate a human clinical trial for an epigenetic therapy for a common infectious disease.

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company focused on developing innovative immunotherapies for infectious diseases and associated cancers, announced late-breaking data ...

Hepatitis B virus (HBV) infection is a leading cause of chronic liver diseases that spreads among individuals through blood ...